Publications of the SFB 1321

Publications



Mass spectrometry-based draft of the mouse proteome


Giansanti, P., Samaras, P., Bian, Y., Meng, C., Coluccio, A., Frejno, M., Jakubowsky, H., Dobiasch, S., Hazarika, R. R., Rechenberger, J., Calzada-Wack, J., Krumm, J., Mueller, S., Lee, C. Y., Wimberger, N., Lautenbacher, L., Hassan, Z., Chang, Y. C., Falcomata, C., Bayer, F. P., Barthel, S., Schmidt, T., Rad, R., Combs, S. E., The, M., Johannes, F., Saur, D., de Angelis, M. H., Wilhelm, M., Schneider, G., and Kuster, B. (2022). Nat Methods 19, 803-811. doi: 10.1038/s41592-022-01526-y

Drain use in pancreatic surgery: Results from an international survey among experts in the field


Pergolini, I., Schorn, S., Goess, R., Novotny, A. R., Ceyhan, G. O., Friess, H., International Pancreatic Surgery, C., and Demir, I. E. (2022). Surgery 172, 265-272. doi: 10.1016/j.surg.2021.11.023

Adipose cells and tissues soften with lipid accumulation while in diabetes adipose tissue stiffens


Abuhattum, S., Kotzbeck, P., Schlussler, R., Harger, A., de Schellenberger, A. A., Kim, K., Escolano, J. C., Muller, T., Braun, J., Wabitsch, M., Tschop, M., Sack, I., Brankatschk, M., Guck, J., Stemmer, K., and Taubenberger, A. V. (2022). Sci Rep 12. doi: ARTN 10325 10.1038/s41598-022-13324-9

Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review


Vornhulz, M., Anton, S., Eross, B., Szakacs, Z., Hegyi, P., Regel, I., Belka, C., Niyazi, M., Mayerle, J., and Beyer, G. (2022). Radiat Oncol 17, 108. doi: 10.1186/s13014-022-02076-5

ChipCytometry for multiplexed detection of protein and mRNA markers on human FFPE tissue samples


Jarosch, S., Kohlen, J., Wagner, S., D'Ippolito, E., and Busch, D. H. (2022). STAR Protoc 3, 101374. doi: 10.1016/j.xpro.2022.101374

MALDI Mass Spectrometry Imaging for the Distinction of Adenocarcinomas of the Pancreas and Biliary Tree


Bollwein, C., Gonalves, J. P. L., Utpatel, K., Weichert, W., and Schwamborn, K. (2022). Molecules 27. doi: 10.3390/molecules27113464

Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype


Orben, F., Lankes, K., Schneeweis, C., Hassan, Z., Jakubowsky, H., Krauss, L., Boniolo, F., Schneider, C., Schafer, A., Murr, J., Schlag, C., Kong, B., Ollinger, R., Wang, C., Beyer, G., Mahajan, U. M., Xue, Y., Mayerle, J., Schmid, R. M., Kuster, B., Rad, R., Braun, C. J., Wirth, M., Reichert, M., Saur, D., and Schneider, G. (2022). JCI Insight 7. doi: 10.1172/jci.insight.151353

Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment


Roy-Luzarraga, M., Reynolds, L. E., de Luxan-Delgado, B., Maiques, O., Wisniewski, L., Newport, E., Rajeeve, V., Drake, R. J. G., Gomez-Escudero, J., Richards, F. M., Weller, C., Dormann, C., Meng, Y. M., Vermeulen, P. B., Saur, D., Sanz-Moreno, V., Wong, P. P., Geraud, C., Cutillas, P. R., and Hodivala-Dilke, K. (2022). Cancer Res 82, 1909-1925. doi: 10.1158/0008-5472.CAN-20-3807

HLA-DRB1*16 and-DQB1*05 alleles are strongly associated with autoimmune pancreatitis in a cohort of hundred patients


Goni, E., Regel, I., Mahajan, U. M., Amodio, A., De Marchi, G., Beyer, G., Zuppardo, R. A., Di Leo, M., Lanzillotta, M., Bonatti, F., Kauke, T., Dick, A., Weiss, F. U., Schonermarck, U., Lerch, M. M., Frulloni, L., Cavestro, G. M., and Mayerle, J. (2022). Pancreatology 22, 466-471. doi: 10.1016/j.pan.2022.03.015

Single-cell profiling guided combination therapy of c-Fos and histone deacetylase inhibitors in diffuse large B-cell lymphoma


Kramer, O. H., and Schneider, G. (2022). Clin Transl Med 12, e858. doi: 10.1002/ctm2.858